PH24857A - Recombinant human endothelial cell growth factor - Google Patents

Recombinant human endothelial cell growth factor

Info

Publication number
PH24857A
PH24857A PH34950A PH34950A PH24857A PH 24857 A PH24857 A PH 24857A PH 34950 A PH34950 A PH 34950A PH 34950 A PH34950 A PH 34950A PH 24857 A PH24857 A PH 24857A
Authority
PH
Philippines
Prior art keywords
endothelial cell
growth factor
cell growth
recombinant human
human endothelial
Prior art date
Application number
PH34950A
Other languages
English (en)
Inventor
Michael Jaye
Wilson Burgess
Thomas Maciag
William Drohan
Original Assignee
Rorer Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer Biotechnology filed Critical Rorer Biotechnology
Publication of PH24857A publication Critical patent/PH24857A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH34950A 1986-03-03 1987-03-03 Recombinant human endothelial cell growth factor PH24857A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/835,594 US4868113A (en) 1986-03-03 1986-03-03 Recombinant DNA vector encoding human endothelial cell growth factor

Publications (1)

Publication Number Publication Date
PH24857A true PH24857A (en) 1990-12-26

Family

ID=25269917

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34950A PH24857A (en) 1986-03-03 1987-03-03 Recombinant human endothelial cell growth factor

Country Status (16)

Country Link
US (1) US4868113A (de)
EP (1) EP0259475B1 (de)
JP (4) JPS63502725A (de)
KR (1) KR960002874B1 (de)
AT (1) ATE110782T1 (de)
AU (1) AU617086B2 (de)
DE (1) DE3750451T2 (de)
DK (1) DK175807B1 (de)
FI (1) FI874819A (de)
HK (1) HK1002123A1 (de)
IE (1) IE66307B1 (de)
NZ (1) NZ219485A (de)
PH (1) PH24857A (de)
RU (1) RU1804480C (de)
UA (1) UA13321A (de)
WO (1) WO1987005332A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401832A (en) * 1984-12-24 1995-03-28 Merck & Co., Inc. Brain derived and recombinant acidic fibroblast growth factor
WO1989000198A1 (en) * 1987-07-07 1989-01-12 Biotechnology Research Associates, J.V. Recombinant fibroblast growth factors
EP0593065B1 (de) * 1985-09-12 2002-08-21 Scios Inc. Rekombinante Fibroblasten-Wachstums-Faktoren
US5552528A (en) * 1986-03-03 1996-09-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bovine b-endothelial cell growth factor
US5827826A (en) 1986-03-03 1998-10-27 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compositions of human endothelial cell growth factor
NZ220917A (en) * 1986-07-11 1991-05-28 Merck & Co Inc Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
NZ226543A (en) * 1987-10-22 1992-02-25 Merck & Co Inc Recombinant mutant acidic fibroblast growth factor
US5312911A (en) * 1987-10-22 1994-05-17 Merck & Co., Inc. Cysteine-modified acidic fibroblast growth factor
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
GB2223497B (en) * 1988-08-08 1992-04-01 British Bio Technology Synthetic gene encoding human beta endothelial cell growth factor
GB2223496B (en) * 1988-08-08 1992-05-27 British Bio Technology Synthetic gene encoding mature human acid fibroblast growth factor
US5656458A (en) * 1988-11-04 1997-08-12 Chiron Corporation Expression and processing of amino terminus acetylated FGF's in yeast
ATE141643T1 (de) * 1988-11-04 1996-09-15 Chiron Corp Expression und prozessierung von acetylierten fgfs in hefen
US5227302A (en) * 1988-12-20 1993-07-13 Ludwig Institute For Cancer Research DNA encoding platelet derived endothelial cell growth factor (PD-ECGF)
US5756686A (en) * 1988-12-20 1998-05-26 Ludwig Institute For Cancer Research Peptides derived from endothelial cell growth factor
HU218090B (hu) 1989-01-31 2000-05-28 Stuart A. Aaronson Eljárás hámsejtekre specifikus növekedési faktor és az ezt kódoló DNS, az ez ellen termelődött antitestek valamint a növekedési faktort vagy az antitestet tartalmazó gyógyászati készítmények előállítására
US7026291B1 (en) 1989-01-31 2006-04-11 The United States Of America As Represented By The Department Of Health And Human Services Epithelial cell specific growth factor, keratinocyte growth factor (KGF)
US5595887A (en) * 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
US5244460A (en) * 1991-11-27 1993-09-14 The United States Of America As Represented By The Department Of Health And Human Services Method to foster myocardial blood vessel growth and improve blood flow to the heart
US5348941A (en) * 1992-04-01 1994-09-20 Merck & Co., Inc. Stabilizers for fibroblast growth factors
US5656598A (en) * 1994-03-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Use of fibroblast growth factors to stimulate bone growth
CA2184916C (en) * 1994-03-08 2008-05-13 Colin R. Dunstan Use of fibroblast growth factors to stimulate bone growth
US5817485A (en) * 1994-03-08 1998-10-06 Human Genome Sciences, Inc. Nucleic acids and cells for recombinant production of fibroblast growth factor-10
US20050019824A1 (en) * 1994-03-08 2005-01-27 Human Genome Sciences, Inc. Fibroblast Growth Factor-10
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
AU712297B2 (en) * 1995-06-05 1999-11-04 Human Genome Sciences, Inc. Fibroblast growth factor 11
US6110893A (en) * 1995-06-05 2000-08-29 Human Genome Sciences, Inc. Fibroblast growth factor 11
US6605441B1 (en) * 1995-06-05 2003-08-12 Human Genome Sciences, Inc. Antibodies against fibroblast growth factor 11
WO1996041818A1 (en) * 1995-06-09 1996-12-27 Drohan William N Chitin hydrogels, methods of their production and use
US5876730A (en) * 1997-08-07 1999-03-02 Childrens Hospital Research Foundation Heparin-binding growth factor (HBGF) polypeptides
US6645947B1 (en) 1999-05-20 2003-11-11 Chitogenics, Inc. Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
US6719805B1 (en) * 1999-06-09 2004-04-13 C. R. Bard, Inc. Devices and methods for treating tissue
WO2002034285A2 (en) 2000-10-20 2002-05-02 Coolidge Thomas R Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide
US6982170B1 (en) 2001-12-17 2006-01-03 Maine Medical Center Research Institute Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1
US7265097B2 (en) * 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
ATE513823T1 (de) * 2004-08-17 2011-07-15 Simpson Biotech Co Ltd Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung
US8357146B2 (en) * 2005-05-18 2013-01-22 Cooltouch Incorporated Treatment of cellulite and adipose tissue with mid-infrared radiation
US8256429B2 (en) * 2005-05-18 2012-09-04 Cooltouch Incorporated Treatment of cellulite and adipose tissue with mid-infrared radiation
US8276590B2 (en) 2005-05-18 2012-10-02 Cooltouch Incorporated Thermally mediated tissue molding
US20070134204A1 (en) * 2005-12-09 2007-06-14 Henrich Cheng Method for treating nerve injury and vector construct for the same
JP2011121882A (ja) * 2009-12-09 2011-06-23 Eu Sol Biotech Co Ltd ヒト酸性繊維芽細胞増殖因子の改変ペプチド

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0593065B1 (de) * 1985-09-12 2002-08-21 Scios Inc. Rekombinante Fibroblasten-Wachstums-Faktoren

Also Published As

Publication number Publication date
EP0259475B1 (de) 1994-08-31
DE3750451T2 (de) 1994-12-22
AU617086B2 (en) 1991-11-21
JPH10175999A (ja) 1998-06-30
IE870535L (en) 1987-09-03
RU1804480C (ru) 1993-03-23
JPH09135690A (ja) 1997-05-27
UA13321A (uk) 1997-02-28
FI874819A0 (fi) 1987-11-02
JPH09294590A (ja) 1997-11-18
EP0259475A4 (de) 1989-10-12
JP3372464B2 (ja) 2003-02-04
EP0259475A1 (de) 1988-03-16
DK572487A (da) 1987-11-02
NZ219485A (en) 1990-02-26
HK1002123A1 (en) 1998-07-31
DK572487D0 (da) 1987-11-02
DE3750451D1 (de) 1994-10-06
DK175807B1 (da) 2005-03-07
KR880700858A (ko) 1988-04-12
US4868113A (en) 1989-09-19
IE66307B1 (en) 1995-12-27
KR960002874B1 (ko) 1996-02-27
WO1987005332A1 (en) 1987-09-11
ATE110782T1 (de) 1994-09-15
JPS63502725A (ja) 1988-10-13
FI874819A (fi) 1987-11-02
JP3273354B2 (ja) 2002-04-08
AU7201287A (en) 1987-09-28

Similar Documents

Publication Publication Date Title
HK1002123A1 (en) Recombinant human endothelial cell growth factor
DE69333802T8 (de) Äusseres membranprotein von haemophilus
GR3004903T3 (de)
DE3684892D1 (de) Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens.
WO1994003620A3 (en) Method of increasing expression of viral proteins
ATE71632T1 (de) Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression.
WO2000034474A3 (en) Growth factor homolog zvegf3
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
IE871871L (en) Cloning and expression of acidic fibroblast growth factor
AU8209187A (en) Hybrid proteins
HK1007333A1 (en) Variants of plasminogen activatos and processes for their production
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ES8802441A1 (es) Procedimiento para preparar laminina humana
HUP9901161A2 (hu) Módosított aktivitású hibrid VIII. faktor
AU650649B2 (en) Human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis, DNA synthesis and migration
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
HUP0001057A2 (hu) A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus
TH4656EX (th) รีคอมบิแนนท์ เอนโดเธเลียล เซลล์โกรว์ธ แฟกเตอร์ของมนุษย์
TH4656A (th) รีคอมบิแนนท์ เอนโดเธเลียล เซลล์โกรว์ธ แฟกเตอร์ของมนุษย์
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
PT85226A (en) Process for the preparation of novel trombolytic proteins